Position in PFE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,602,605,180
+$383,676,448 QoQ
Shares Held
92,685,370
+4.0% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 40.92552362902581.ToString("F0")%
Shared 0.ToString("F0")%
None 59.074476370974196.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $57,054,147,722 across 20 Drug Manufacturers - General names. PFE ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437,458 | $14,198,910,733 | |
| 2 | JNJ |
Johnson & Johnson
|
44,721,167 | $10,931,642,052 | |
| 3 | ABBV |
AbbVie Inc.
|
38,016,774 | $8,268,268,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,632,487 | $5,729,711,852 | |
| 5 | AMGN |
Amgen Inc
|
15,836,058 | $5,571,916,998 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,299,295 | $3,247,222,731 | |
| 7 | PFE |
Pfizer Inc
This page
|
92,685,370 | $2,602,605,180 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,198,554 | $1,770,892,290 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,602,605,180 | 92,685,370 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,218,928,732 | 89,113,604 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,905,156,358 | 74,770,658 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,700,079,857 | 70,135,308 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,038,408,306 | 80,442,317 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,960,508,361 | 73,897,790 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,256,486,983 | 77,971,216 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,167,673,434 | 77,472,246 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $2,353,001,276 | 84,792,839 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $2,363,847,160 | 82,106,536 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,817,055,179 | 84,927,802 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $3,102,364,092 | 84,579,174 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,290,496,696 | 80,649,429 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,073,547,250 | 79,499,361 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,154,195,937 | 72,079,432 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,803,714,441 | 72,548,435 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,452,590,647 | 47,374,747 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,778,529,600 | 47,053,846 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,006,589,610 | 46,654,025 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,875,532,168 | 47,894,080 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,677,884,769 | 46,312,028 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,973,388,182 | 53,610,111 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,604,138,909 | 46,069,866 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,343,127,203 | 43,292,190 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,406,060,140 | 45,404,087 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||